CDR2 anticorps (C-Term)
Aperçu rapide pour CDR2 anticorps (C-Term) (ABIN363590)
Antigène
Voir toutes CDR2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- Reacts with ~51 kDa CDR2 protein from human, mouse, bovine, primate
-
Réactivité croisée
- Rat (Rattus)
-
Réactivité croisée (Details)
- May cross react with rat (85 % sequence homology).
-
Purification
- Antigen affinity purified
-
Immunogène
- Synthetic peptide made to a C-terminal region of the human protein
-
-
-
-
Indications d'application
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
- IHC : 5 to 10 μg/mL - WB : 2 μg/mL -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- Tris-citrate, phosphate, ( pH 7-8) buffer, Sodium azide 0.1 %
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C/-80 °C
-
Stockage commentaire
- Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
-
-
- CDR2 (Cerebellar Degeneration-Related Protein 2, 62kDa (CDR2))
-
Autre désignation
- Cerebellar Degeneration-Related Protein 2
Antigène
-